64B9-15.0026. Medication Administration Outside the Scope of Practice of a CNA  


Effective on Wednesday, March 13, 2024
  • 1(1) Aspects of medication administration tasks which have been delegated by a licensed registered nurse and are associated with medication administration to a patient of a home health agency by a certified nursing assistant or to a resident of a nursing home facility by a certified nursing assistant who is providing services as a qualified medication aide, which are outside the scope of practice of the certified nursing assistant and which shall not be performed by the certified nursing assistant include the following:

    84(a) Admintsration of controlled substances listed in Schedule II, Schedule III, or Schedule IV of Section 100893.03, F.S., 102or 10321 U.S.C. s. 812;

    107(b) Administration by subcutaneous, intramuscular, or intravenous injection 115except for an insulin syringe prefilled with the proper dosage by a pharmacist or an insulin pen prefilled by the manufacturer;

    136(c) Legend drugs without original labeling identifying the patient, medication, dose, route and frequency of administration, prescriber, and expiration date.

    156(d) Over-the-counter, non-prescription, medications without an order from a physician licensed under Chapter 458, F.S., an osteopathic physician licensed under Chapter 459, F.S., a podiatric physician licensed under Chapter 461, F.S., or an advanced practice registered nurse licensed under Section 196464.012 197or 198464.0123, F.S.;

    200(e) Over-the-counter, non-prescription, medications not in the original packaging from the manufacturer.

    212(2) Although this rule limits the scope of practice of certified nursing assistants who meet the requirements of Rule 64B9-15.0025, F.A.C., authorized to administer medications to a patient of a home health agency or resident of a nursing home facility as delegated by a registered nurse, it is appropriate for certified nursing assistants who are not authorized to administer medications to care for patients receiving such medications.

    279Rulemaking Authority 281400.211(5), 282464.2035(3), FS. 284Law Implemented 286400.211(5), 287464.0156, FS., 289464.2035. 290History–New 7-15-21, Amended 3-13-24.